Novel Imperial Parameters of Insulin Resistance and Insulin Secretion Function Damage Assessment for Differential Diagnosis of T1DM and LADA from T2DM

被引:0
|
作者
Cao, Xiao
Cui, Shi Wei
Gu, Yun Juan
Zhu, Xiao Hui
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2510-PUB
引用
收藏
页码:A654 / A654
页数:1
相关论文
共 50 条
  • [11] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [12] Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients
    Rui, Xuefei
    Xu, Bei
    Su, Junlei
    Pan, Chunping
    Zhan, Chenyu
    Su, Bin
    Li, Hong
    Wang, Jiying
    Sheng, Hui
    Qu, Shen
    MEDICAL SCIENCE MONITOR, 2014, 20 : 711 - 719
  • [14] UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS
    Nada, Ahmed Hossney
    Ibrahim, Ismail A.
    Shalabi, Laila
    Oteri, Vittorio
    Asar, Nada Khalid
    Aqeilan, Saja Rami
    Hafez, Wael
    ATHEROSCLEROSIS, 2024, 399
  • [15] Arterial Change Determinants in Children and Adolescents with T1DM and T2DM
    Joo, Eunyoung
    Kim, Sujin
    Lee, Jieun
    DIABETES, 2023, 72
  • [16] How does leptin decrease hyperglycaemia in T1DM and T2DM?
    Claire Greenhill
    Nature Reviews Endocrinology, 2014, 10 (9) : 511 - 511
  • [17] Residual insulin secretion is exhibited in many patients with chronic T1DM
    Digon, B
    Rother, K
    Hirshberg, B
    Harlan, D
    DIABETES, 2003, 52 : A219 - A219
  • [18] Insulin Recommender Systems for T1DM: A Review
    Massana, Joaquim
    Torrent-Fontbona, Ferran
    Lopez, Beatriz
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 331 - 355
  • [19] Islet cell function is as interesting as insulin resistance for T2DM treatment options
    Goeke, Burkhard
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 1 - 1
  • [20] Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in the Canadian payer setting
    Kapor, Jovana
    Minshall, Michael E.
    Tunis, Sandra L.
    Conner, Chris
    Mccormick, John
    Seager, Christine
    Groleau, Danielle
    DIABETES, 2008, 57 : A98 - A98